Risks From Stopping Cancer Trials Early!

Risks From Stopping Cancer Trials Early!

0:00

Giovanni Apolone In this edition of Audio News, presented by Peter Goodwin, Giovanni Apolone (Mario Negri Institute, Milan) and Stuart Pocock (London School of Hygiene and Tropical Medicine), talk abo

Giovanni Apolone

Giovanni Apolone

In this edition of Audio News, presented by Peter Goodwin,Giovanni Apolone(Mario Negri Institute, Milan) andStuart Pocock(London School of Hygiene and Tropical Medicine), talk about:

Risks From Stopping Cancer Trials Early!– A report from Annals of Oncology, April 9th, 2008.

Stuart Pocock

Stuart Pocock

A new publication highlights the danger of stopping cancer clinical trials early following interim analysis before originally planned sample-sizes have been reached.

LISTEN

Add to iTunes

Related Episodes

Hassan Mohammed Abushukair MD; AACR 2026: Immune Checkpoint Inhibitor-Induced Myocarditis within One Month Predicts Lethal “Triple M Overlap Syndrome”

Hassan Mohammed Abushukair MD; AACR 2026: Immune Checkpoint Inhibitor-Induced Myocarditis within One Month Predicts Lethal “Triple M Overlap Syndrome”

Immune Checkpoint Inhibitor-Induced Myocarditis within One Month Predicts Lethal “Triple M Overlap Syndrome” An interview with: Hassan Mohammed Abushukair MD, Post-Doctoral Researcher, Oklahoma Univer